School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Instil Bio, Inc. TIL

Healthcare · Biotechnology

$6.74last close 2026-10-09 · market cap $45.71M · delayed data

Trailing returns

1M-11.08%
3M-12.01%
6M-20.47%
1Y-67.52%
5Y-98.12%

Basis: Adjusted daily closes.

What it does

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Open TIL in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies